GLPwatch
Trials (2083)
Page 27 of 35.
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Liraglutide 3 mg for Knee Osteoarthritis
- WEgovy Real World Assessment of Weight Loss in Korea
- Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
- Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
- A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
- In-market Utilisation of Liraglutide Used for Weight Management in Europe
- Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
- Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
- Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Semaglutide and Preoperative Residual Gastric Volumes
- A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
- Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
- Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
- Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
- Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
- Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
- The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
- A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
- The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
- A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
- Reward Mechanisms in Obesity
- A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
- A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
- Latino Semaglutide Study
- Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
- Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
- Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
- Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Protein Supplementation Intervention on Body Weight
- Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
- Safety and Tolerability of NN9068 in Healthy Male Volunteers
- Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
- A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
- Effects of Insulin Glargine and Lixisenatide on the Brain
- Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
- Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
- Exeantide in Type 2 Diabetes on Insulin
- A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Pharmacogenomics of GLP1 Receptor Agonists
- GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
- GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
- Study of RO6807952 in Patients With Diabetes Mellitus Type 2
- Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
- Weight Loss With Exenatide Treatment
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations
- A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity